Serveur d'exploration sur la grippe en Allemagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008.

Identifieur interne : 000409 ( Main/Exploration ); précédent : 000408; suivant : 000410

Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008.

Auteurs : E. Terletskaia-Ladwig [Allemagne] ; M. Eggers ; S. Meier ; M. Leinmüller ; F. Schneider ; M. Schmid ; M. Enders

Source :

RBID : pubmed:19669087

Descripteurs français

English descriptors

Abstract

BACKGROUND

In Germany, the cost for PCR diagnosis of influenza in ambulant patients was not covered by the national statutory health insurance system until 2008. Therefore, cell culture was the standard method applied for routine diagnosis. We have prospectively compared a 1-day rapid cell culture assay (RCA) with conventional cell culture (CCC) during the influenza seasons from 1997/1998 to 2007/2008 and with real-time PCR analysis during the influenza seasons 2003/2004 and 2006/2007.

PATIENTS AND METHODS

This study is based on 4,262 respiratory samples obtained from ambulant patients between January 1998 and May 2008. The RCA was performed in microtiter plates that were stained with monoclonal antibodies to influenza virus A and B 16 h after inoculation.

RESULTS

A total of 1,221 specimens were found to be positive by the cell culture methods - 1,143 (93.6%) by the RCA and 1,012 (82.9%) by the CCC. The sensitivity of the RCA and CCC versus PCR was 75.4% (221/293) and 58% (170/293), respectively. The specificity of both cell culture assays versus PCR was 100%. Influenza A represented 79.3% of the cases diagnosed. An increased activity of influenza was observed between January and March, with the rate of influenza-positive cases being highest for kindergarten and school-aged children.

CONCLUSION

While PCR is the most sensitive assay for the diagnosis of influenza, the RCA can still be used for diagnosis and surveillance of this disease. Based on our findings and given the known fact that influenza antibodies reach a plateau 2-4 weeks after immunization, the optimal time for vaccination in Germany is from October through November. Kindergarten and school-aged children represent an important reservoir of infection. Consequently, routine immunization should be considered for this age group to prevent the spread of influenza.


DOI: 10.1007/s15010-009-8434-7
PubMed: 19669087


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008.</title>
<author>
<name sortKey="Terletskaia Ladwig, E" sort="Terletskaia Ladwig, E" uniqKey="Terletskaia Ladwig E" first="E" last="Terletskaia-Ladwig">E. Terletskaia-Ladwig</name>
<affiliation wicri:level="3">
<nlm:affiliation>Labor Prof. Gisela Enders und Partner und Institut für Virologie, Infektiologie und Epidemiologie e.V, Stuttgart, Germany. ladwig@labor-enders.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Labor Prof. Gisela Enders und Partner und Institut für Virologie, Infektiologie und Epidemiologie e.V, Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Eggers, M" sort="Eggers, M" uniqKey="Eggers M" first="M" last="Eggers">M. Eggers</name>
</author>
<author>
<name sortKey="Meier, S" sort="Meier, S" uniqKey="Meier S" first="S" last="Meier">S. Meier</name>
</author>
<author>
<name sortKey="Leinmuller, M" sort="Leinmuller, M" uniqKey="Leinmuller M" first="M" last="Leinmüller">M. Leinmüller</name>
</author>
<author>
<name sortKey="Schneider, F" sort="Schneider, F" uniqKey="Schneider F" first="F" last="Schneider">F. Schneider</name>
</author>
<author>
<name sortKey="Schmid, M" sort="Schmid, M" uniqKey="Schmid M" first="M" last="Schmid">M. Schmid</name>
</author>
<author>
<name sortKey="Enders, M" sort="Enders, M" uniqKey="Enders M" first="M" last="Enders">M. Enders</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19669087</idno>
<idno type="pmid">19669087</idno>
<idno type="doi">10.1007/s15010-009-8434-7</idno>
<idno type="wicri:Area/Main/Corpus">000399</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000399</idno>
<idno type="wicri:Area/Main/Curation">000399</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000399</idno>
<idno type="wicri:Area/Main/Exploration">000399</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008.</title>
<author>
<name sortKey="Terletskaia Ladwig, E" sort="Terletskaia Ladwig, E" uniqKey="Terletskaia Ladwig E" first="E" last="Terletskaia-Ladwig">E. Terletskaia-Ladwig</name>
<affiliation wicri:level="3">
<nlm:affiliation>Labor Prof. Gisela Enders und Partner und Institut für Virologie, Infektiologie und Epidemiologie e.V, Stuttgart, Germany. ladwig@labor-enders.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Labor Prof. Gisela Enders und Partner und Institut für Virologie, Infektiologie und Epidemiologie e.V, Stuttgart</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Stuttgart</region>
<settlement type="city">Stuttgart</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Eggers, M" sort="Eggers, M" uniqKey="Eggers M" first="M" last="Eggers">M. Eggers</name>
</author>
<author>
<name sortKey="Meier, S" sort="Meier, S" uniqKey="Meier S" first="S" last="Meier">S. Meier</name>
</author>
<author>
<name sortKey="Leinmuller, M" sort="Leinmuller, M" uniqKey="Leinmuller M" first="M" last="Leinmüller">M. Leinmüller</name>
</author>
<author>
<name sortKey="Schneider, F" sort="Schneider, F" uniqKey="Schneider F" first="F" last="Schneider">F. Schneider</name>
</author>
<author>
<name sortKey="Schmid, M" sort="Schmid, M" uniqKey="Schmid M" first="M" last="Schmid">M. Schmid</name>
</author>
<author>
<name sortKey="Enders, M" sort="Enders, M" uniqKey="Enders M" first="M" last="Enders">M. Enders</name>
</author>
</analytic>
<series>
<title level="j">Infection</title>
<idno type="eISSN">1439-0973</idno>
<imprint>
<date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Animals (MeSH)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Clinical Laboratory Techniques (methods)</term>
<term>Germany (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Infant, Newborn (MeSH)</term>
<term>Influenza, Human (diagnosis)</term>
<term>Influenza, Human (virology)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Orthomyxoviridae (genetics)</term>
<term>Orthomyxoviridae (growth & development)</term>
<term>Orthomyxoviridae (isolation & purification)</term>
<term>Polymerase Chain Reaction (methods)</term>
<term>Prospective Studies (MeSH)</term>
<term>Sensitivity and Specificity (MeSH)</term>
<term>Virus Cultivation (methods)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Allemagne (MeSH)</term>
<term>Animaux (MeSH)</term>
<term>Culture virale (méthodes)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Grippe humaine (diagnostic)</term>
<term>Grippe humaine (virologie)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Mâle (MeSH)</term>
<term>Nourrisson (MeSH)</term>
<term>Nouveau-né (MeSH)</term>
<term>Orthomyxoviridae (croissance et développement)</term>
<term>Orthomyxoviridae (génétique)</term>
<term>Orthomyxoviridae (isolement et purification)</term>
<term>Réaction de polymérisation en chaîne (méthodes)</term>
<term>Sensibilité et spécificité (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Techniques de laboratoire clinique (méthodes)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en">
<term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Orthomyxoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Clinical Laboratory Techniques</term>
<term>Polymerase Chain Reaction</term>
<term>Virus Cultivation</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr">
<term>Culture virale</term>
<term>Réaction de polymérisation en chaîne</term>
<term>Techniques de laboratoire clinique</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Animals</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Sensitivity and Specificity</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Allemagne</term>
<term>Animaux</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Sensibilité et spécificité</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>In Germany, the cost for PCR diagnosis of influenza in ambulant patients was not covered by the national statutory health insurance system until 2008. Therefore, cell culture was the standard method applied for routine diagnosis. We have prospectively compared a 1-day rapid cell culture assay (RCA) with conventional cell culture (CCC) during the influenza seasons from 1997/1998 to 2007/2008 and with real-time PCR analysis during the influenza seasons 2003/2004 and 2006/2007.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>PATIENTS AND METHODS</b>
</p>
<p>This study is based on 4,262 respiratory samples obtained from ambulant patients between January 1998 and May 2008. The RCA was performed in microtiter plates that were stained with monoclonal antibodies to influenza virus A and B 16 h after inoculation.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>A total of 1,221 specimens were found to be positive by the cell culture methods - 1,143 (93.6%) by the RCA and 1,012 (82.9%) by the CCC. The sensitivity of the RCA and CCC versus PCR was 75.4% (221/293) and 58% (170/293), respectively. The specificity of both cell culture assays versus PCR was 100%. Influenza A represented 79.3% of the cases diagnosed. An increased activity of influenza was observed between January and March, with the rate of influenza-positive cases being highest for kindergarten and school-aged children.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>While PCR is the most sensitive assay for the diagnosis of influenza, the RCA can still be used for diagnosis and surveillance of this disease. Based on our findings and given the known fact that influenza antibodies reach a plateau 2-4 weeks after immunization, the optimal time for vaccination in Germany is from October through November. Kindergarten and school-aged children represent an important reservoir of infection. Consequently, routine immunization should be considered for this age group to prevent the spread of influenza.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">19669087</PMID>
<DateCompleted>
<Year>2010</Year>
<Month>06</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1439-0973</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>37</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2009</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Infection</Title>
<ISOAbbreviation>Infection</ISOAbbreviation>
</Journal>
<ArticleTitle>Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008.</ArticleTitle>
<Pagination>
<MedlinePgn>401-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-009-8434-7</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In Germany, the cost for PCR diagnosis of influenza in ambulant patients was not covered by the national statutory health insurance system until 2008. Therefore, cell culture was the standard method applied for routine diagnosis. We have prospectively compared a 1-day rapid cell culture assay (RCA) with conventional cell culture (CCC) during the influenza seasons from 1997/1998 to 2007/2008 and with real-time PCR analysis during the influenza seasons 2003/2004 and 2006/2007.</AbstractText>
<AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">This study is based on 4,262 respiratory samples obtained from ambulant patients between January 1998 and May 2008. The RCA was performed in microtiter plates that were stained with monoclonal antibodies to influenza virus A and B 16 h after inoculation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1,221 specimens were found to be positive by the cell culture methods - 1,143 (93.6%) by the RCA and 1,012 (82.9%) by the CCC. The sensitivity of the RCA and CCC versus PCR was 75.4% (221/293) and 58% (170/293), respectively. The specificity of both cell culture assays versus PCR was 100%. Influenza A represented 79.3% of the cases diagnosed. An increased activity of influenza was observed between January and March, with the rate of influenza-positive cases being highest for kindergarten and school-aged children.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">While PCR is the most sensitive assay for the diagnosis of influenza, the RCA can still be used for diagnosis and surveillance of this disease. Based on our findings and given the known fact that influenza antibodies reach a plateau 2-4 weeks after immunization, the optimal time for vaccination in Germany is from October through November. Kindergarten and school-aged children represent an important reservoir of infection. Consequently, routine immunization should be considered for this age group to prevent the spread of influenza.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Terletskaia-Ladwig</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Labor Prof. Gisela Enders und Partner und Institut für Virologie, Infektiologie und Epidemiologie e.V, Stuttgart, Germany. ladwig@labor-enders.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Eggers</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Meier</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Leinmüller</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schneider</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Schmid</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Enders</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D023362">Evaluation Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2009</Year>
<Month>08</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Infection</MedlineTA>
<NlmUniqueID>0365307</NlmUniqueID>
<ISSNLinking>0300-8126</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009975" MajorTopicYN="N">Orthomyxoviridae</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014776" MajorTopicYN="N">Virus Cultivation</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2008</Year>
<Month>11</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2009</Year>
<Month>02</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2009</Year>
<Month>8</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2009</Year>
<Month>8</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2010</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">19669087</ArticleId>
<ArticleId IdType="doi">10.1007/s15010-009-8434-7</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Clin Microbiol. 1989 Nov;27(11):2505-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2808674</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol Methods. 1989 Apr-May;24(1-2):35-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2668316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2001 Sep 24;161(17):2116-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11570941</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2005 Jun;33(2):172-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15911434</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Jpn J Infect Dis. 2008 May;61(3):196-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18503168</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Biol (Basel). 2003;115:63-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15088777</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 1990 Jul;28(7):1669-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2380390</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2003 Jun 7;326(7401):1235</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12791735</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infection. 2007 Apr;35(2):65-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17401709</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Med Dir Assoc. 2006 Jan;7(1):37-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16413433</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2008 Jul;46(7):2189-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18480230</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 1998 Feb;36(2):340-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9466738</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2002 Dec;7(12):180-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12631984</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2006 Sep;44(9):3366-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16954274</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2003 Aug;41(8):3487-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12904343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2007 Mar;38(3):210-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17229589</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diagn Microbiol Infect Dis. 2007 Jan;57(1):67-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17178298</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2007 Dec 12;2(12):e1296</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18074020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 1995 Feb;33(2):318-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7714186</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2008 Jul;42(3):264-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18467164</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2002 Jun;40(6):2051-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12037063</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Diagn Virol. 1995 Oct;4(3):251-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15566845</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2004 Mar;29(3):179-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14962787</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
<region>
<li>Bade-Wurtemberg</li>
<li>District de Stuttgart</li>
</region>
<settlement>
<li>Stuttgart</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Eggers, M" sort="Eggers, M" uniqKey="Eggers M" first="M" last="Eggers">M. Eggers</name>
<name sortKey="Enders, M" sort="Enders, M" uniqKey="Enders M" first="M" last="Enders">M. Enders</name>
<name sortKey="Leinmuller, M" sort="Leinmuller, M" uniqKey="Leinmuller M" first="M" last="Leinmüller">M. Leinmüller</name>
<name sortKey="Meier, S" sort="Meier, S" uniqKey="Meier S" first="S" last="Meier">S. Meier</name>
<name sortKey="Schmid, M" sort="Schmid, M" uniqKey="Schmid M" first="M" last="Schmid">M. Schmid</name>
<name sortKey="Schneider, F" sort="Schneider, F" uniqKey="Schneider F" first="F" last="Schneider">F. Schneider</name>
</noCountry>
<country name="Allemagne">
<region name="Bade-Wurtemberg">
<name sortKey="Terletskaia Ladwig, E" sort="Terletskaia Ladwig, E" uniqKey="Terletskaia Ladwig E" first="E" last="Terletskaia-Ladwig">E. Terletskaia-Ladwig</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000409 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000409 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeAllemagneV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:19669087
   |texte=   Laboratory-based assessment of influenza in German ambulant patients from 1998 to 2008.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:19669087" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV4 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Mon Aug 10 17:53:30 2020. Site generation: Sat Mar 27 17:40:37 2021